approval · primary record
VANDETANIB
FDA · NDA · 2026-01-27
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-01-27 |
| Brand | CAPRELSA |
| Sponsor | GENZYME CORP |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:38:35.317Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:VANDETANIB:2026-01-27
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Vandetanib · compound